Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorFinance
Current SymbolNYSE:CI
Previous Symbol
CUSIP12550910
Phone860-226-6000
Debt
Debt-to-Equity Ratio1.61
Current Ratio0.98
Quick Ratio0.98
Price-To-Earnings
Trailing P/E Ratio20.79
Forward P/E Ratio15.15
P/E Growth1.23
Sales & Book Value
Annual Sales$41.62 billion
Price / Sales1.27
Cash Flow$13.1055 per share
Price / Cash16.59
Book Value$63.87 per share
Price / Book3.40
Profitability
EPS (Most Recent Fiscal Year)$10.46
Net Income$2.24 billion
Net Margins6.15%
Return on Equity23.31%
Return on Assets5.01%
Miscellaneous
Employees46,000
Outstanding Shares243,530,000
Market Cap$53.01 billion
OptionableOptionable
CIGNA (NYSE:CI) Frequently Asked Questions
What is CIGNA's stock symbol?
CIGNA trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."
How often does CIGNA pay dividends? What is the dividend yield for CIGNA?
CIGNA announced a quarterly dividend on Wednesday, February 28th. Stockholders of record on Monday, March 12th will be paid a dividend of $0.04 per share on Tuesday, April 10th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.07%. The ex-dividend date of this dividend is Friday, March 9th. View CIGNA's Dividend History.
How will CIGNA's stock buyback program work?
CIGNA announced that its Board of Directors has initiated a share buyback plan on Sunday, June 4th 2017, which authorizes the company to buyback $3,700,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 9.8% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its stock is undervalued.
How were CIGNA's earnings last quarter?
CIGNA Co. (NYSE:CI) announced its earnings results on Thursday, November, 1st. The health services provider reported $3.84 EPS for the quarter, beating the Zacks' consensus estimate of $3.45 by $0.39. The health services provider had revenue of $11.45 billion for the quarter, compared to analyst estimates of $11.19 billion. CIGNA had a return on equity of 23.31% and a net margin of 6.15%. The firm's quarterly revenue was up 10.3% compared to the same quarter last year. During the same period last year, the company posted $2.83 earnings per share. View CIGNA's Earnings History.
When is CIGNA's next earnings date?
What guidance has CIGNA issued on next quarter's earnings?
CIGNA updated its FY 2018 earnings guidance on Thursday, November, 1st. The company provided earnings per share (EPS) guidance of $14.20-14.40 for the period, compared to the Thomson Reuters consensus estimate of $13.84. The company issued revenue guidance of $45.153-45.153 billion, compared to the consensus revenue estimate of $45.18 billion.
What price target have analysts set for CI?
13 brokers have issued 12-month target prices for CIGNA's stock. Their forecasts range from $194.00 to $255.00. On average, they anticipate CIGNA's share price to reach $234.7692 in the next year. This suggests a possible upside of 8.0% from the stock's current price. View Analyst Price Targets for CIGNA.
What is the consensus analysts' recommendation for CIGNA?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CIGNA in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CIGNA.
What are Wall Street analysts saying about CIGNA stock?
Here are some recent quotes from research analysts about CIGNA stock:
- 1. According to Zacks Investment Research, "Shares of Cigna have outperformed its industry's growth in a year's time. The company is on track to buy Express Scripts, which should raise its rank in the health insurance industry. The company has recieved approval for the merger from the Department of Justice. Synergies from the acquisition should buoy the company's long-term growth potential. A robust Global Supplemental business, growing Government business, increasing membership, and strong capital position are the other positives. Strong 2018 outlook reflects business strength. However, increase in leverage, suspension of share buybackl are concerns. Its Medicare business is expected to grow less than the industry average." (10/9/2018)
- 2. Cantor Fitzgerald analysts commented, ". We initiate coverage of Overweight rating and a 12-month price target of $245. Cigna is a large-cap health insurance company with a focus on self-insured employers. Segment accounted for 80% of operating revenue and 77% of adjusted operating income. The company also operates supplemental benefits and group disability and life businesses. the company announced the acquisition of Express Scripts (ESRX – Not Covered), a large pharmacy benefit manager (PBM). We believe the transaction, which should close by year-end 2018, is a logical fit, both strategically and financially, with natural synergies." (9/26/2018)
Has CIGNA been receiving favorable news coverage?
Press coverage about CI stock has been trending somewhat positive on Monday, InfoTrie reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CIGNA earned a media sentiment score of 1.3 on InfoTrie's scale. They also assigned media headlines about the health services provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days.
Who are some of CIGNA's key competitors?
Who are CIGNA's key executives?
CIGNA's management team includes the folowing people:
- Mr. David Michael Cordani, Pres, CEO & Director (Age 53)
- Mr. Eric Paul Palmer, Exec. VP & CFO (Age 41)
- Ms. Nicole Susan Jones, Exec. VP & Gen. Counsel (Age 47)
- Mr. Jason D. Sadler, Pres of International Markets (Age 49)
- Ms. Mary Terese Agoglia Hoeltzel CPA, VP & Chief Accounting Officer
Who are CIGNA's major shareholders?
CIGNA's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.93%), FMR LLC (3.68%), Massachusetts Financial Services Co. MA (2.24%), Veritas Asset Management LLP (1.91%), Sanders Capital LLC (1.43%) and Bank of New York Mellon Corp (0.87%). Company insiders that own CIGNA stock include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Eric P Palmer, Hoeltzel Mary T Agoglia, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for CIGNA.
Which institutional investors are selling CIGNA stock?
CI stock was sold by a variety of institutional investors in the last quarter, including Swedbank, MERIAN GLOBAL INVESTORS UK Ltd, Levin Capital Strategies L.P., BlackRock Inc., Eagle Asset Management Inc., LSV Asset Management, Canada Pension Plan Investment Board and Janus Henderson Group PLC. Company insiders that have sold CIGNA company stock in the last year include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Hoeltzel Mary T Agoglia, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Michael W Triplett, Nicole S Jones and William D Zollars. View Insider Buying and Selling for CIGNA.
Which institutional investors are buying CIGNA stock?
CI stock was purchased by a variety of institutional investors in the last quarter, including Ruffer LLP, FMR LLC, DNB Asset Management AS, Assenagon Asset Management S.A., FIL Ltd, Hexavest Inc., Veritas Asset Management LLP and Sanders Capital LLC. View Insider Buying and Selling for CIGNA.
How do I buy shares of CIGNA?
Shares of CI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CIGNA's stock price today?
One share of CI stock can currently be purchased for approximately $217.42.
How big of a company is CIGNA?
CIGNA has a market capitalization of $53.01 billion and generates $41.62 billion in revenue each year. The health services provider earns $2.24 billion in net income (profit) each year or $10.46 on an earnings per share basis. CIGNA employs 46,000 workers across the globe.
What is CIGNA's official website?
How can I contact CIGNA?
CIGNA's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider can be reached via phone at 860-226-6000 or via email at [email protected]
MarketBeat Community Rating for CIGNA (NYSE CI)
MarketBeat's community ratings are surveys of what our community members think about CIGNA and other stocks. Vote "Outperform" if you believe CI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CI will underperform the S&P 500 over the long term. You may vote once every thirty days.
